Expres2ion Biotech

Upcoming events

• 19/05/21

  Interim report, Q1 2021

• 26/05/21

  Annual General Meeting, 2021

• 19/08/21

  Half-year report, 2021

• 18/11/21

  Interim report, Q3 2021

• 24/02/22

  Year-end report, 2022

Latest press releases

Lead candidate selected in ExpreS2ion’s HER2-cVLP breast cancer vaccine project

11-05-2021 Regulatory pressrelease

Hørsholm, Denmark, May 11, 2021 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") announces the selection of its lead candidate HER2-cVLP breast cancer vaccine. The project runs according to plan.

Read more

ExpreS2ion - Annual report for 2020 published

05-05-2021 Regulatory pressrelease

Hørsholm, Denmark, May 05, 2021 – ExpreS2ion Biotech Holding AB (“ExpreS2ion”) hereby announces that the company's annual report for the financial year 2020 is published. The annual report is available as an attachment and on ExpreS2ion's website (www.expres2ionbio.com).

Read more

View all